Event Details
Crinetics will hold a live webcast on Tuesday, March 12 at 4:30 p.m. EDT to discuss data from Phase 2 study of paltusotine in carcinoid syndrome.
News & Events
Crinetics Presents Data from Phase 2 Study of Paltusotine in Carcinoid Syndrome
Transforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
